Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Hydroxychloroquine may help COVID-19 patients with lupus.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Baricitinib is effective as a treatment for severe hair loss.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Early intervention is important for limited systemic sclerosis patients due to higher pain and ulceration risks.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Calcitriol and metformin together are more effective for treating PCOS and lowering MCP-1 than metformin alone.

Methotrexate plus prednisolone had the fewest serious side effects.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.